WUXI06:BKK
우시바이오로직스
THB 3.54
arrow_upward
+1.14%(+0.040) 1D
4월 29일, 오후 4시 28분 40초 GMT+7 · THB
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoWUXI06의 주요 통계 생성 중...
시가
THB 3.50
고가
THB 3.56
저가
THB 3.50
시가총액
1404.37억
평균 거래량
4.73만
거래량
10.80만
52주 최고가
THB 4.28
52주 최저가
THB 3.16
유통 주식수
25.00억
직원 수
1만
뉴스 기사
웹 소스 기반
TheStreet Pro
·
10분 전
Keeping an Eye on the Nasdaq
Yahoo Finance
·
1시간 전
Why The Narrative Around H World Group (NasdaqGS:HTHT) Is Shifting On Margins Mix And Valuation
Benzinga
·
1시간 전
나스닥, 기술주 매도세 속 200p 이상 급락···투자자 심리 위축, 공포 지수 여전히 ‘탐욕’ 영역
Bloomberg.com
·
1시간 전
Nasdaq-Listed MakeMyTrip Said to Hire Banks for India Offering
프로필
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
우시바이오로직스에 관한 정보